Showing results (1-10 of 43) with videos related to
Sort By:
Pageof 5
Advances in Cancer Research|October 24, 2012
HDAC inhibitors: roles of DNA damage and repairCarine Robert, Feyruz V RassoolCellular and Molecular Life Sciences : CMLS|August 11, 2010
Targeting abnormal DNA double strand break repair in cancerFeyruz V Rassool, Alan E TomkinsonBiochimica Et Biophysica Acta|September 22, 2012
DNA double-strand break response in stem cells: mechanisms to maintain genomic integrityPratik Nagaria, Carine Robert, Feyruz V RassoolCancer Research|May 15, 2025
Combining STING Agonists with PARP Inhibitors Mounts an NK-Dependent Defense against Therapy-Resistant Breast CancerZahra Gohari, Lora Stojanovic, Feyruz V RassoolBlood|June 6, 2008
Up-regulation of WRN and DNA ligase IIIalpha in chronic myeloid leukemia: consequences for the repair of DNA double-strand breaksAnnahita Sallmyr, Alan E Tomkinson, Feyruz V RassoolCancers|June 10, 2022
Pharmacologic Induction of BRCAness in BRCA-Proficient Cancers: Expanding PARP Inhibitor UseRachel Abbotts, Anna J Dellomo, Feyruz V RassoolCancer Research|April 6, 2021
How Epigenetic Therapy Beats Adverse Genetics in Monosomy Karyotype AMLHeather M O'Hagan, Feyruz V Rassool, Kenneth P NephewCancer Research|May 23, 2002
Myeloid leukemias have increased activity of the nonhomologous end-joining pathway and concomitant DNA misrepair that is dependent on the Ku70/86 heterodimerTerry J Gaymes, Ghulam J Mufti, Feyruz V RassoolCancer Letters|April 7, 2019
Partnering with PARP inhibitors in acute myeloid leukemia with FLT3-ITDAnna J Dellomo, Maria R Baer, Feyruz V RassoolLeukemia Research|March 12, 2010
Regulation of differentiation by a PHD domain in the NUP98-PHF23 fusion proteinJocelyn C Reader, Qixin Leng, Feyruz V Rassool, et al.Pageof 5